Digestive Disease & Surgery Institute Outcomes
Gallbladder and Abdominal Surgery
Cholecystectomy
Cholecystectomy 30-Day Outcomes (Elective and Non-Elective Cases)
2021 - 2022
| 30 Day Outcomes | 2021 % (N=619) | 2022 % (N=493) |
|---|---|---|
| Readmission | 4 | 2 |
| Procedural Re-Intervention (CD III)* | 2 | 1 |
| Bile Leak | 1 | 0 |
Data Source: Cleveland Clinic, Digestive Disease and Surgery Institute Quality Collaborative
*Any procedural intervention as defined by Clavien Dindo III – “Requiring surgical, endoscopic or radiological intervention"
Data include Main Campus, Fairview, and Hillcrest
Cholecystectomy Intraoperative Outcomes
2021 - 2022
2021 % (N) | 2022 % (N) | |
|---|---|---|
| MIS Conversion, Non-elective | 3 (311) | 3 (25) |
| MIS Conversion, Elective | 1 (893) | 1 (776) |
| Bile Duct Injury, Non-Elective | 0 (319) | 0 (258) |
| Bile Duct Injury, Elective | 0 (907) | 0 (788) |
Data Source: Cleveland Clinic, Digestive Disease and Surgery Institute Quality Collaborative
MIS = minimally invasive surgery
Data include Main Campus, Fairview, and Hillcrest
